| CAT--the new committee for advanced therapies at the European Medicines Agency. | |
| | |
MedLine Citation:
|
PMID: 20084354 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The Regulation on Advanced Therapies (Regulation (EC) 1394/2007) establishes a new scientific committee, the Committee for Advanced Therapies (CAT), at the European Medicines Agency. The CAT is composed of experts in the field of Advanced Therapy Medicinal Products (ATMPs)--gene and cell therapy and tissue engineered products--and is responsible for the evaluation of the marketing authorisation applications for this novel class of products. The CAT is also involved in all scientific advice on ATMPs and in two new regulatory procedures for ATMPs, the classification and the certification procedures. The CAT will also play a key role in early contacts with developers of ATMPs. |
| | |
Authors:
|
P Celis |
Related Documents
:
|
17943924 - Pyrrolidinyl-spirooxindole natural products as inspirations for the development of pote... 7783304 - The independent practice association in theory and practice. lessons from experience. 8764624 - Centennial of röntgen's discovery of x-rays. 10165944 - Managing the gap: balancing advances in technology with advances in management practice. 11971124 - Symptomatic therapy for underrecognized manifestations of multiple sclerosis. 16151894 - Living with phenylketonuria: perspectives of patients and their families. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz Volume: 53 ISSN: 1437-1588 ISO Abbreviation: Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz Publication Date: 2010 Jan |
Date Detail:
|
Created Date: 2010-01-25 Completed Date: 2010-04-30 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101181368 Medline TA: Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz Country: Germany |
Other Details:
|
Languages: eng Pagination: 9-13 Citation Subset: IM |
Affiliation:
|
European Medicines Agency, London, United Kingdom. patrick.celis@emea.europa.eu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Advisory Committees
/
legislation & jurisprudence Cell Transplantation / legislation & jurisprudence* Certification / legislation & jurisprudence Clinical Trials as Topic / legislation & jurisprudence Consumer Product Safety / legislation & jurisprudence* Europe Gene Therapy / legislation & jurisprudence* Humans Marketing of Health Services / legislation & jurisprudence* Quality Assurance, Health Care / legislation & jurisprudence* Tissue Engineering / legislation & jurisprudence* |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: [New cross-sectional guidelines of the German Medical Association for hemotherapy with fresh frozen ...
Next Document: Naturopathic practitioners and the public health system : Legal principles as well as experience fro...